Subgroup analysis of double-blind, placebo-controlled Ph. 2 study of nanvuranlat in treatment of pre-treated, advanced, refractory biliary tract cancer (BTC): Patients with high LAT1 expression and ...

Worldwide, squamous cell carcinoma remains the predominant histology, however, adenocarcinoma of the esophagus and gastroesophageal (GE) junction cancer is now more prevalent than squamous cell ...